SCHEMBL7390725

SCHEMBL7390725

[c]1cccc(-c2ccccc2)c1Cn1ccnc1

nearest known ligand 0.62

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ CYP11B1 P15538 18/20 0.62
▸ CYP11B2 P19099 17/20 0.62
▸ CYP17A1 P05093 1/20 0.54
▸ CYP1A2 P05177 1/20 0.51
▸ POLB P06746 1/20 0.51
▸ CYP3A4 P08684 1/20 0.51
▸ CYP2D6 P10635 1/20 0.51
▸ MAPT P10636 1/20 0.51
▸ CYP19A1 P11511 1/20 0.51
▸ TBXAS1 P24557 1/20 0.51
▸ QPCT Q16769 1/20 0.51
▸ CYP4Z1 Q86W10 1/20 0.51
▸ QPCTL Q9NXS2 1/20 0.51
▸ PDE4A P27815 1/20 0.47
▸ MEN1 O00255 1/20 0.47
▸ KMT2A Q03164 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7392131 0.88 CYP11B1 (0.51) CYP11B1CYP11B2CYP17A1CYP1A2POLB
SCHEMBL7389176 0.83 CYP19A1 (0.47) CYP11B1CYP11B2CYP17A1CYP1A2POLB
SCHEMBL7391276 0.82 CYP11B1 (0.47) CYP11B1CYP11B2CYP17A1CYP1A2POLB
SCHEMBL906443 0.77 CYP11B1 (1.00) CYP11B1CYP11B2CYP17A1CYP1A2POLB
SCHEMBL9067044 0.75 CYP11B1 (0.94) CYP11B1CYP11B2CYP17A1CYP1A2POLB
SCHEMBL5545363 0.72 CYP11B1 (0.78) CYP11B1CYP11B2CYP17A1CYP1A2POLB
SCHEMBL1865702 0.72 CYP11B1 (0.56) CYP11B1CYP11B2CYP17A1CYP1A2POLB
SCHEMBL7390727 0.71 CYP11B1 (0.61) CYP11B1CYP11B2CYP17A1CYP1A2POLB
SCHEMBL21408487 0.71 DPP4 (0.50) CYP3A4CYP2D6
SCHEMBL2033990 0.70 CYP11B1 (1.00) CYP11B1CYP11B2CYP17A1CYP1A2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6060491-A ANTICOAGULANTS; THROMBOEMBOLIC DISORDERS; PROPHYLAXIS DUPONT PHARMACEUTICALS (US) 2000-05-09 — — US disclosed
EP-0993448-A1 (AMIDINO)6-MEMBERED AROMATICS AS FACTOR Xa INHIBITORS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 2000-04-19 — — EP disclosed
EP-0991625-A2 INHIBITORS OF FACTOR XA WITH A NEUTRAL P1 SPECIFICITY GROUP THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 2000-04-12 — — EP disclosed
US-5998424-A ANTICOAGULANTS DUPONT PHARMACEUTICALS COMPANY (US) 1999-12-07 — — US disclosed
WO-1998057937-A2 INHIBITORS OF FACTOR XA WITH A NEUTRAL P1 SPECIFICITY GROUP THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1998-12-23 — — WO disclosed
WO-1998057934-A1 (AMIDINO)6-MEMBERED AROMATICS AS FACTOR Xa INHIBITORS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1998-12-23 — — WO disclosed
Send feedback